Loading company…
Purui Jizhun provides data analytics and research services for precision oncology and drug development.
Founded in 2015 and based in Beijing, China, Purui Jizhun provides data-driven solutions for oncology research and drug development, including target discovery, biomarker identification, and therapy recommendations. It offers the AIBERT® analytics platform and CRO services such as laboratory work, diagnostic development, and regulatory strategy. In December 2025, the company raised Series D funding from Hongyuan Huifu Capital, GIG Capital Management Group, SND Ventures Group, and returning investor Shenzhen Salubris Pharmaceuticals.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in